Vanberra Signal

AbSci

Curated by Signal

Developer of AI based technology for the production of recombinant protein for therapeutic applications

Overview

Developer of AI based technology for the production of recombinant protein for therapeutic applications. The company's integrated drug creation platform enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Key facts

Founded
2011

Business model

Contact

Open roles

20 roles
  • Director, Program Management

    New York, NY · On-site · Volunteer

  • Director, Program Management

    Vancouver, WA · On-site · Volunteer

  • Staff/Principal AI Scientist - Virtual Tissue

    United States · On-site · Volunteer

+ 17 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More High Technology companies
  • Developer of VR/AR books for children

    High TechnologyLos Angeles, United States
  • Provider of an AI and cloud-based chatbot service solution for enterprises

    High TechnologyHouston, United States
  • AR/VR solutions for life science and healthcare education & training

    High TechnologySuwanee, United States

About AbSci

What does AbSci do?

Developer of AI based technology for the production of recombinant protein for therapeutic applications.

Where is AbSci headquartered?

AbSci is headquartered in Vancouver, United States.

When was AbSci founded?

AbSci was founded in 2011.

Which sector is AbSci in?

AbSci operates in High Technology.

Who are AbSci's competitors?

Companies similar to AbSci include Quantum Storey, Chatbot Portal, and Mpect.

Is AbSci hiring?

Yes. AbSci has 20 open roles listed on Vanberra Signal.